Uday P. Kulkarni

Ida Scudder Road
Vellore, TN 632004, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 86 publications

Outcomes of Adults Age 40 Years and Older With Newly Diagnosed ALL: A Multicenter Registry Analysis From the Hematology Cancer Consortium.

Outcomes of Adults Age 40 Years and Older With Newly Diagnosed ALL: A Multicenter Registry Analysis From the Hematology Cancer Consortium.

Journal: JCO global oncology

Published: July 29, 2026

The Last Mile in CAR-T Cell Therapy.

The Last Mile in CAR-T Cell Therapy.

Journal: Transplantation and cellular therapy

Published: June 29, 2026

Efficacy of Standard-Dose Versus Low-Dose Nivolumab in Relapsed/Refractory Hodgkin Lymphoma-A Retrospective Analysis.

Efficacy of Standard-Dose Versus Low-Dose Nivolumab in Relapsed/Refractory Hodgkin Lymphoma-A Retrospective Analysis.

Journal: JCO global oncology

Published: February 27, 2026

Emergency splenectomy in immune thrombocytopenia presenting with intracranial hemorrhage.

Emergency splenectomy in immune thrombocytopenia presenting with intracranial hemorrhage.

Journal: Haematologica

Published: January 25, 2026

Prognostic Implications and Therapeutic Landscape of IDH1-Mutated AML: An Updated Review of Evidence and Indian Perspective.

Prognostic Implications and Therapeutic Landscape of IDH1-Mutated AML: An Updated Review of Evidence and Indian Perspective.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: November 11, 2025

Challenges and considerations in developing trispecific CAR-Ts for B-cell malignancies.

Challenges and considerations in developing trispecific CAR-Ts for B-cell malignancies.

Journal: Expert opinion on biological therapy

Published: October 28, 2025

Real world outcomes with the use of Inotuzumab Ozogamicin in relapsed/refractory B cell acute lymphoblastic leukemia.

Real world outcomes with the use of Inotuzumab Ozogamicin in relapsed/refractory B cell acute lymphoblastic leukemia.

Journal: Blood cancer journal

Published: October 17, 2025

Acquired Cutis Laxa Secondary to Hematological Malignancy: A Report of Two Cases.

Acquired Cutis Laxa Secondary to Hematological Malignancy: A Report of Two Cases.

Journal: Indian dermatology online journal

Published: October 06, 2025

Clinical Outcomes of Allogeneic Stem Cell Transplantation in Myelofibrosis - A Single Center Experience.

Clinical Outcomes of Allogeneic Stem Cell Transplantation in Myelofibrosis - A Single Center Experience.

Journal: Blood cell therapy

Published: July 04, 2025

Recurrent Orogenital Ulcers: A Rare Case of Myeloid Neoplasm Associated with FIP1L1-PDGFRA Rearrangement with Rapid Response to Imatinib.

Recurrent Orogenital Ulcers: A Rare Case of Myeloid Neoplasm Associated with FIP1L1-PDGFRA Rearrangement with Rapid Response to Imatinib.

Journal: Indian dermatology online journal

Published: June 25, 2025

Cytogenetic Profile of Acute Lymphoblastic Leukaemia in South India: A Series of 1,819 Patients from a Single Centre.

Cytogenetic Profile of Acute Lymphoblastic Leukaemia in South India: A Series of 1,819 Patients from a Single Centre.

Journal: Cytogenetic and genome research

Published: June 17, 2025

Clinical Presentation, Microbiological Profile, Treatment Outcome, and Predictors of Outcome in Patients with Nontuberculous Mycobacteria Bloodstream Infection.

Clinical Presentation, Microbiological Profile, Treatment Outcome, and Predictors of Outcome in Patients with Nontuberculous Mycobacteria Bloodstream Infection.

Journal: International journal of mycobacteriology

Published: June 02, 2025

Showing 1-12 of 86

Last Updated: 09/26/2026